These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 26196461)

  • 1. Response Strategies against Meningitis Epidemics after Elimination of Serogroup A Meningococci, Niger.
    Maïnassara HB; Paireau J; Idi I; Pelat JP; Oukem-Boyer OO; Fontanet A; Mueller JE
    Emerg Infect Dis; 2015 Aug; 21(8):1322-9. PubMed ID: 26196461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of response strategies against epidemics due to Neisseria meningitidis C in Niger.
    Maïnassara HB; Oumarou GI; Issaka B; Sidiki A; Idi I; Pelat JM; Fontanet A; Mueller JE
    Trop Med Int Health; 2017 Feb; 22(2):196-204. PubMed ID: 27860062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clonal expansion of Neisseria meningitidis W135. Epidemiological implications for the African meningitis belt].
    du Châtelet IP; Alonso JM; Taha MK
    Bull Soc Pathol Exot; 2002 Dec; 95(5):323-4; discussion 324-5. PubMed ID: 12696368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiological patterns of meningococcal meningitis in Niger in 2003 and 2004: under the threat of N. meningitidis serogroup W135.
    Boisier P; Djibo S; Sidikou F; Mindadou H; Kairo KK; Djibo A; Goumbi K; Chanteau S
    Trop Med Int Health; 2005 May; 10(5):435-43. PubMed ID: 15860090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meningococcal Meningitis Outbreaks in the African Meningitis Belt After Meningococcal Serogroup A Conjugate Vaccine Introduction, 2011-2017.
    Fernandez K; Lingani C; Aderinola OM; Goumbi K; Bicaba B; Edea ZA; Glèlè C; Sarkodie B; Tamekloe A; Ngomba A; Djingarey M; Bwaka A; Perea W; Ronveaux O
    J Infect Dis; 2019 Oct; 220(220 Suppl 4):S225-S232. PubMed ID: 31671449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meningococcal meningitis: unprecedented incidence of serogroup X-related cases in 2006 in Niger.
    Boisier P; Nicolas P; Djibo S; Taha MK; Jeanne I; Maïnassara HB; Tenebray B; Kairo KK; Giorgini D; Chanteau S
    Clin Infect Dis; 2007 Mar; 44(5):657-63. PubMed ID: 17278055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of serogroup X meningococcal disease in Africa: need for a vaccine.
    Xie O; Pollard AJ; Mueller JE; Norheim G
    Vaccine; 2013 Jun; 31(27):2852-61. PubMed ID: 23623866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiological and epidemiological investigation of the Neisseria meningitidis serogroup A epidemic in Niger in 2009: last wave before the introduction of the serogroup A meningococcal conjugate vaccine?
    Collard JM; Maman Z; Abani A; Mainasara HB; Djibo S; Yacouba H; Maitournam R; Sidikou F; Nicolas P; Rocourt J; Jusot JF
    Epidemiol Infect; 2011 Nov; 139(11):1656-60. PubMed ID: 21251346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergency vaccination against epidemic meningitis in Ghana: implications for the control of meningococcal disease in West Africa.
    Woods CW; Armstrong G; Sackey SO; Tetteh C; Bugri S; Perkins BA; Rosenstein NE
    Lancet; 2000 Jan; 355(9197):30-3. PubMed ID: 10615888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study [corrected].
    Daugla DM; Gami JP; Gamougam K; Naibei N; Mbainadji L; Narbé M; Toralta J; Kodbesse B; Ngadoua C; Coldiron ME; Fermon F; Page AL; Djingarey MH; Hugonnet S; Harrison OB; Rebbetts LS; Tekletsion Y; Watkins ER; Hill D; Caugant DA; Chandramohan D; Hassan-King M; Manigart O; Nascimento M; Woukeu A; Trotter C; Stuart JM; Maiden M; Greenwood BM
    Lancet; 2014 Jan; 383(9911):40-47. PubMed ID: 24035220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An epidemic of meningococcal meningitis in the region of Savanes in Togo in 1997: research and control strategies].
    Aplogan A; Batchassi E; Yakoua Y; Croisier A; Aleki A; Schlumberger M; Molina S; Sidatt M; Kaninda AV
    Sante; 1997; 7(6):384-90. PubMed ID: 9503496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response thresholds for epidemic meningitis in sub-Saharan Africa following the introduction of MenAfriVac®.
    Trotter CL; Cibrelus L; Fernandez K; Lingani C; Ronveaux O; Stuart JM
    Vaccine; 2015 Nov; 33(46):6212-7. PubMed ID: 26463444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of epidemic Neisseria meningitidis serogroup C in Niger, 2015: an analysis of national surveillance data.
    Sidikou F; Zaneidou M; Alkassoum I; Schwartz S; Issaka B; Obama R; Lingani C; Tate A; Ake F; Sakande S; Ousmane S; Zanguina J; Seidou I; Nzeyimana I; Mounkoro D; Abodji O; Wang X; Taha MK; Moulia-Pelat JP; Pana A; Kadade G; Ronveaux O; Novak R; Oukem-Boyer OOM; Meyer S;
    Lancet Infect Dis; 2016 Nov; 16(11):1288-1294. PubMed ID: 27567107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outbreaks of serogroup X meningococcal meningitis in Niger 1995-2000.
    Djibo S; Nicolas P; Alonso JM; Djibo A; Couret D; Riou JY; Chippaux JP
    Trop Med Int Health; 2003 Dec; 8(12):1118-23. PubMed ID: 14641847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of a meningococcal meningitis outbreak in Niger - potential effectiveness of reactive prophylaxis.
    Hitchings MDT; Coldiron ME; Grais RF; Lipsitch M
    PLoS Negl Trop Dis; 2019 Mar; 13(3):e0007077. PubMed ID: 30856166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conjugate vaccine introduction in the African meningitis belt: meeting surveillance objectives.
    Mueller JE
    Trop Med Int Health; 2013 Jan; 18(1):58-64. PubMed ID: 23121399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemiological and control aspects of meningococcal meningitis epidemics in Africa].
    Spiegel A; Moren A; Varaine F; Baudon D; Rey M
    Sante; 1994; 4(3):231-6. PubMed ID: 7921694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatiotemporal Analysis of Serogroup C Meningococcal Meningitis Spread in Niger and Nigeria and Implications for Epidemic Response.
    Cooper LV; Ronveaux O; Fernandez K; Lingani C; Goumbi K; Ihekweazu C; Preziosi MP; Durupt A; Trotter CL
    J Infect Dis; 2019 Oct; 220(220 Suppl 4):S244-S252. PubMed ID: 31671446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meningococcal meningitis: vaccination outbreak response and epidemiological changes in the African meningitis belt.
    Carod Artal FJ
    Int Health; 2015 Jul; 7(4):226-7. PubMed ID: 25878213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence and control of epidemic meningococcal meningitis in sub-Saharan Africa.
    Mohammed I; Iliyasu G; Habib AG
    Pathog Glob Health; 2017 Feb; 111(1):1-6. PubMed ID: 28081671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.